| Study of RVT-1401 for the Treatment of Patients With Moderate to Severe Active Graves' Ophthalmopathy (GO) (NCT03922321) | Immunovant Sciences GmbH | 2019-04-22 |
| The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant Recipients (NCT03685773) | Albert Einstein College of Medicine | 2019-04-21 |
| Neural and Antidepressant Effects of Propofol (NCT03684447) | University of Utah | 2019-04-21 |
| Non-Steroidal or Opioid Analgesia Use for Children With Musculoskeletal Injuries (NCT03767933) | University of Alberta | 2019-04-20 |
| MESO-CAR T Cells Therapy for Relapsed and Refractory Epithelial Ovarian Cancer (NCT03916679) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2019-04-20 |
| TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection (NCT03964493) | TenNor Therapeutics Limited | 2019-04-20 |
| Lenvatinib Combined Pembrolizumab in Advanced Hepatobiliary Tumors (NCT03895970) | Peking Union Medical College Hospital | 2019-04-20 |
| Pentoxifylline Add-on Therapy for Schizophrenia (NCT05073640) | Mazra Mental Health Center | 2019-04-20 |
| The Optimal Dose of Mannitol for Intraoperative Brain Relaxation During the Operation of Aneurysmal Subarachnoid Hemorrhage (NCT04135456) | Beijing Tiantan Hospital | 2019-04-20 |
| A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (NCT03738150) | Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA | 2019-04-19 |
| Pyrotinib Combined With Capecitabine Metronomic Therapy in HER2-postitive Advanced Breast Cancer (NCT03923166) | Chinese Academy of Medical Sciences | 2019-04-19 |
| Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis (NCT03835767) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-04-19 |
| IRX-2, Cyclophosphamide, and Pembrolizumab in Treating Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Cancer (NCT03918499) | City of Hope Medical Center | 2019-04-19 |
| Effectiveness of an Opioid Sparing Pain Regimen in Cardiac Surgery (NCT03679013) | Inova Health Care Services | 2019-04-19 |
| Phase II Clinical Study of Pyrotinib Combined With Etoposide to Treat HER2-positive Advanced Breast Cancer (NCT03923179) | Chinese Academy of Medical Sciences | 2019-04-19 |
| Denosumab for Smoldering Multiple Myeloma (NCT03839459) | University of Rochester | 2019-04-19 |
| Ruxolitinib for Bronchiolitis Obliterans Syndrome (BOS) After Allogeneic Hematopoietic Cell Transplantation (HCT) (NCT03674047) | Massachusetts General Hospital | 2019-04-19 |
| Safety and Efficacy Study of ATGC-100 for the Treatment of Moderate to Severe Glabellar Lines in Adult Subjects (NCT03970876) | EuBiologics Co.,Ltd | 2019-04-19 |
| D-0120 Safety and PK/PD Study in China (NCT03923868) | InventisBio Co., Ltd | 2019-04-18 |
| A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) (NCT03845517) | Pfizer | 2019-04-18 |
| Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma (NCT03922724) | National Cancer Institute (NCI) | 2019-04-18 |
| Phase 1b Study of Pegylated Liposomal Doxorubicin and Pembrolizumab in Endocrine-resistant Breast Cancer (NCT03591276) | Shaare Zedek Medical Center | 2019-04-18 |
| Nutritional Strategies for Metabolic Health in Aging (NCT04282603) | University of Alaska Fairbanks | 2019-04-18 |
| A Neurokinin-1 Receptor Antagonist for the Treatment of Pruritus in Patients With Epidermolysis Bullosa (NCT03836001) | Stanford University | 2019-04-18 |
| TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer (NCT03964532) | Georgetown University | 2019-04-17 |
| Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer (NCT03910387) | Emory University | 2019-04-17 |
| A Phase 2 Study to Evaluate Efficacy and Safety of VX-561 in Subjects Aged 18 Years and Older With Cystic Fibrosis (NCT03911713) | Vertex Pharmaceuticals Incorporated | 2019-04-17 |
| Fecal Microbiota Transplantation for Pouchitis (NCT03545386) | McMaster University | 2019-04-17 |
| Allogenic Mesenchymal Stem Cell Derived Exosome in Patients With Acute Ischemic Stroke (NCT03384433) | Isfahan University of Medical Sciences | 2019-04-17 |
| Safety and Pharmacokinetics of ODM-209 (NCT03878823) | Orion Corporation, Orion Pharma | 2019-04-17 |
| Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast Cancers (NCT03911973) | Kari Wisinski | 2019-04-17 |
| Cetuximab in Head and Neck Cancer Patients (NCT03769311) | University of Wisconsin, Madison | 2019-04-17 |
| Study to Evaluate the Safety and Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED) (NCT03889886) | Silk Technologies, Ltd. | 2019-04-16 |
| M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (NCT03840902) | EMD Serono Research & Development Institute, Inc. | 2019-04-16 |
| To Reduce the Use of Chemotherapy in Postmenopausal Patients With ER-positive and HER2-positive Breast Cancer (TOUCH) (NCT03644186) | ETOP IBCSG Partners Foundation | 2019-04-16 |
| Daratumumab-bortezomib-dexamethasone (Dara-VCd) vs Bortezomib-Thalidomide-Dexamethasone (VTd), Then Maintenance With Ixazomib (IXA) or IXA-Dara (NCT03896737) | European Myeloma Network B.V. | 2019-04-16 |
| Comparison of Standard vs. Accelerated Corneal Crosslinking (NCT03922542) | Price Vision Group | 2019-04-16 |
| Study to Evaluate the Safety, Tolerability, PK and PD of PB2452 in Healthy Younger, Older and Elderly Subjects (NCT03928353) | SFJ Pharmaceuticals, Inc. | 2019-04-16 |
| (PIONEER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, Versus Placebo in Patients With Indolent Systemic Mastocytosis (NCT03731260) | Blueprint Medicines Corporation | 2019-04-16 |
| Vitamin C Infusion for TReatment in Sepsis and Alcoholic Hepatitis (NCT03829683) | Virginia Commonwealth University | 2019-04-16 |
| Leflunomide in Previously Treated Metastatic Triple Negative Cancers (NCT03709446) | Joseph Sparano | 2019-04-16 |
| V-Boost Immunotherapy in Glioblastoma Multiforme Brain Cancer (NCT03916757) | Immunitor LLC | 2019-04-16 |
| Neural and Antidepressant Effects of Propofol (Phase 2) (NCT03923361) | University of Utah | 2019-04-16 |
| A Study to Determine Safety of Durvalumab After Sequential Chemo Radiation in Patients With Unresectable Stage III Non-Small Cell Lung Cancer (NCT03693300) | AstraZeneca | 2019-04-16 |
| Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) (NCT03845296) | SWOG Cancer Research Network | 2019-04-16 |
| Dose-finding Study of KHK7791 in Hyperphosphatemia Patients (NCT03864458) | Kyowa Kirin Co., Ltd. | 2019-04-15 |
| Phase 2a Study Examining the Safety and Efficacy of BOL-DP-o-04 for Treating Diabetic Neuropathy (NCT04082000) | Breath of Life International Pharma Ltd | 2019-04-15 |
| PD-L1 ImagiNg to prediCt Durvalumab Treatment Response in HNSCC (NCT03829007) | Radboud University Medical Center | 2019-04-15 |
| Immunotherapy and Chemotherapy in Unresectable Recurrent Loco-regionally Advanced Nasopharyngeal Carcinoma (NCT04921995) | Fudan University | 2019-04-15 |
| Exercise and Nutrition Interventions During Chemotherapy K07 (NCT03858153) | University of Rochester | 2019-04-15 |
| A Study to Evaluate the Safety and Efficacy of Vactosertib and Imatinib in Patients With Advanced Desmoid Tumor (NCT03802084) | Hyo Song Kim | 2019-04-15 |
| PSMA-PET for Biopsy and Treatment Guidance in Primary Prostate Cancer (NCT03429244) | Indiana University | 2019-04-15 |
| Modafinil Versus Amphetamines for the Treatment of Narcolepsy Type 2 and Idiopathic Hypersomnia (NCT03772314) | Emory University | 2019-04-15 |
| This Study Tests Whether BI 425809 Together With Brain Training Using a Computer Improves Mental Functioning in Patients With Schizophrenia (NCT03859973) | Boehringer Ingelheim | 2019-04-15 |
| Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer (NCT03907852) | TCR2 Therapeutics | 2019-04-15 |
| Quetiapine Treatment for Pediatric Delirium (NCT03572257) | Medical College of Wisconsin | 2019-04-15 |
| SinTilimab After Radiation (STAR Study) (NCT04167657) | Peking Union Medical College Hospital | 2019-04-15 |
| Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer (NCT03878849) | Allarity Therapeutics | 2019-04-15 |
| Effect of Cryotherpy on Hypertrophic Scar (NCT04532840) | Zakria Mowafy | 2019-04-15 |
| Phase II of Lenvatinib Plus Toripalimab for Advanced HCC (NCT03919383) | Sun Yat-sen University | 2019-04-15 |
| Tocotrienols for Skeletal Muscle Health (NCT03708354) | Texas Tech University Health Sciences Center | 2019-04-15 |
| A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery (NCT03809000) | RTOG Foundation, Inc. | 2019-04-15 |
| Evaluation the Effects of French Maritime Pine Bark Extract on the Clinical Status in Traumatic Brain Injury Patients (NCT03777683) | Mashhad University of Medical Sciences | 2019-04-14 |
| Diazepam Buccal Film (DBF) - Diastat Rectal Gel (DRG) Crossover Study (NCT03953820) | Aquestive Therapeutics | 2019-04-13 |
| A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis. (NCT03675477) | Reistone Biopharma Company Limited | 2019-04-13 |
| Plerixafor/G-CSF as Additional Agents for Conditioning Before HSCT in CGD Patients (NCT03547830) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2019-04-13 |
| Pharmacologically-based Strategies for Opioid Substitution Therapy During Pregnancy (NCT03831113) | Steve N. Caritis, MD | 2019-04-13 |
| Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDs (NCT04106700) | Instituto de Investigacion Sanitaria La Fe | 2019-04-12 |
| X-396(Ensartinib) Capsules in ALK-Positive NSCLC Patients With Brain Metastases (NCT03753685) | Fudan University | 2019-04-12 |
| Effects of Simvastatin in the Prevention of Pain Experienced After Tooth Extraction (NCT04406883) | Islamic Azad University, Sanandaj | 2019-04-12 |
| Role of ARNi in Ventricular Remodeling in Hypertensive LVH (NCT03553810) | National Heart Centre Singapore | 2019-04-12 |
| Gallium Ga 68-labeled PSMA-11 PET/CT and Fluciclovine F18 PET/CT in Imaging Participants With Recurrent Prostate Cancer After Surgery (NCT03515577) | Jonsson Comprehensive Cancer Center | 2019-04-12 |
| CPX-351 Plus Enasidenib for Relapsed AML (NCT03825796) | Jonsson Comprehensive Cancer Center | 2019-04-12 |
| Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD) (NCT03202303) | Montefiore Medical Center | 2019-04-12 |
| The UNSCARRed Study: UNresctable Squamous Cell Carcinoma Treated With Avelumab and Radical Radiotherapy (NCT03737721) | AHS Cancer Control Alberta | 2019-04-12 |
| Foxy-5 as Neo-Adjuvant Therapy in Subjects With Wnt-5a Low Colon Cancer (NCT03883802) | WntResearch AB | 2019-04-12 |
| Anlotinib After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer（ALTER-L029） (NCT03743129) | Anhui Shi, MD | 2019-04-12 |
| Efficacy and Safety of the Combination of Rucaparib (PARP Inhibitor) and Atezolizumab (Anti-PD-L1 Antibody) in Patients With DNA Repair-deficient or Platinum-sensitive Solid Tumors (NCT04276376) | Gustave Roussy, Cancer Campus, Grand Paris | 2019-04-12 |
| Sacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE Study (NCT04066894) | M.D. Anderson Cancer Center | 2019-04-12 |
| Study of Nasal Insulin to Fight Forgetfulness - Device Study (NCT03857321) | Wake Forest University Health Sciences | 2019-04-12 |
| Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Colorectal Cancer (NCT03906565) | Beijing Biostar Pharmaceuticals Co., Ltd. | 2019-04-12 |
| Bendamustine, Obinutuzumab, and Venetoclax in Patients With Untreated Mantle Cell Lymphoma (NCT03872180) | Emory University | 2019-04-11 |
| Pemetrexed and Avelumab in Treating Patients With MTAP-Deficient Metastatic Urothelial Cancer (NCT03744793) | M.D. Anderson Cancer Center | 2019-04-11 |
| A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver Cirrhosis (NCT03827200) | Noorik Biopharmaceuticals AG | 2019-04-11 |
| Anrotinib in Combination With Capecitabine in Advanced Triple Negative Breast Cancer (NCT05089643) | Chinese Academy of Medical Sciences | 2019-04-11 |
| Ibrutinib Plus Rituximab for cGVHD Following Allo-SCT (NCT03689894) | Dartmouth-Hitchcock Medical Center | 2019-04-11 |
| Daratumumab in Treating Participants With Relapsed Multiple Myeloma After Stem Cell Transplant (NCT03622775) | M.D. Anderson Cancer Center | 2019-04-11 |
| ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB) (NCT03685448) | Australian and New Zealand Urogenital and Prostate Cancer Trials Group | 2019-04-11 |
| Network-Level Mechanisms for Preclinical Alzheimer's Disease Development (NCT03461861) | Medical College of Wisconsin | 2019-04-11 |
| Multi-center Trial of ESK981 in Combination With Nivolumab in Patients With Metastatic Renal Cell Carcinoma (NCT03562507) | University of Michigan Rogel Cancer Center | 2019-04-11 |
| Evaluating the Effects of Inarigivir on Immune Response and Viral Markers in Chronic Hepatitis B Patients (NCT03932513) | F-star Therapeutics, Inc. | 2019-04-11 |
| Feasibility of Combined Focused Ultrasound and Radiotherapy Treatment in Patients With Painful Bone Metastasis (NCT04310410) | UMC Utrecht | 2019-04-11 |
| A Study to Assess Dystrophin Levels in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) Who Have Been Treated With Ataluren (NCT03796637) | PTC Therapeutics | 2019-04-11 |
| Anlotinib Maintenance Treatment for Advanced Soft Tissue Sarcoma (NCT03890068) | Sun Yat-sen University | 2019-04-11 |
| Colchicine for Amyotrophic Lateral Sclerosis (NCT03693781) | Azienda Ospedaliero-Universitaria di Modena | 2019-04-10 |
| Male Partner-assisted Contact Tracing for HIV and Tuberculosis in Malawi (NCT04285905) | Liverpool School of Tropical Medicine | 2019-04-10 |
| Long-Term, Open Label Extension Study of Pemziviptadil (PB1046) in PAH Subjects Following Completion of Study PB1046-PT-CL-0004 (NCT03795428) | PhaseBio Pharmaceuticals Inc. | 2019-04-10 |
| Pinometostat With Standard Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and MLL Gene Rearrangement (NCT03724084) | National Cancer Institute (NCI) | 2019-04-10 |
| Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer (NCT03912818) | Stanford University | 2019-04-10 |
| A Study of Pazopanib and Durvalumab for Metastatic Soft Tissue Sarcoma (NCT03798106) | Yonsei University | 2019-04-10 |